Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry. (Q30575712)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry. |
scientific article |
Statements
Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry (English)
Maria E Zannin
Carolina Birolo
Valeria M Gerloni
Elisabetta Miserocchi
Irene Pontikaki
Maria P Paroli
Alison Shardlow
Fulvio Parentin
Fernanda Falcini
Fabrizia Corona
Stefania Viola
Riccardo De Marco
Luciana Breda
Francesco La Torre
Fabio Vittadello
Giorgia Martini
Francesco Zulian
1 November 2012